Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.86 USD | +10.75% | +18.83% | +92.75% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Larimar Therapeutics Shares Rise 15% Nomlabofusp Selected for FDA Program | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 510M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -138M | EV / Sales 2024 * | - |
Net cash position 2024 * | 185M | Net cash position 2025 * | 59.3M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.13
x | P/E ratio 2025 * |
-3.72
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | +12.68% | ||
1 week | +12.99% | ||
1 month | +5.12% | ||
3 months | -29.52% | ||
6 months | +125.99% | ||
Current year | +75.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 19-12-31 | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 13-12-31 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 8.75 | +9.38% | 715 004 |
24-05-31 | 8 | +12.68% | 1,013,617 |
24-05-30 | 7.1 | +0.42% | 169,472 |
24-05-29 | 7.07 | -4.20% | 309,510 |
24-05-28 | 7.38 | +4.24% | 426,261 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.82% | 510M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- LRMR Stock